dactolisib and Lymphoma--Follicular

dactolisib has been researched along with Lymphoma--Follicular* in 1 studies

Other Studies

1 other study(ies) available for dactolisib and Lymphoma--Follicular

Article	Year
The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma. Leukemia, 2010, Volume: 24, Issue:10 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Female; Forkhead Transcription Factors; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Lymphoma, Follicular; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazines; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2010

Article

Year

The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma.

Leukemia, 2010, Volume: 24, Issue:10

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Female; Forkhead Transcription Factors; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Lymphoma, Follicular; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazines; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010